“Wise Fools”...
June 1, 2012 - Professional Advice / Opinions By: Michael Maddalena, Pharm.D. Candidate c/o 2016 – Michael is the upcoming president of the Phi Delta Chi Professional Pharmaceutical Fraternity Beta Alpha Chapter at St. John’s University College of Pharmacy and Allied Health Professions. The term sophomore comes from a compound of the Greek sophos, meaning “wise”, and moros, meaning “foolish”. Hence, as… |
|
A Reflection of my Palliative Care Rotation...
June 1, 2012 - Professional Advice / Opinions By: Stanley Saji, Pharm.D. Candidate c/o 2013 – I had a preconceived notion that advanced pharmacy practice experiences (APPEs) were just an application of concepts and therapies learned in pharmacy school. Little did I know how real APPEs became… During my third rotation, I worked with Dr. Maha Saad, Assistant Clinical Professor in the Department… |
|
Amnesty International and Pharmacists for Social Justic...
June 1, 2012 - Professional Advice / Opinions By: Ebey P. Soman, Editor-In-Chief – As a member of Amnesty International and a student pharmacist, I have an opportunity to be a force for social justice in this world. Remember the classes titled “Social and Behavioral Aspects of Pharmaceutical Care” or the “Moral Theology of Health Care” that you took as a first or… |
|
An Experience That I Will Never Forget...
June 1, 2012 - Events , Professional Advice / Opinions By: Nancy Simon, Pharm.D. Candidate c/o 2016 – Exploring cities while getting lost, viewing beautiful sights, and eating delicious food: all highlights of my study abroad experience. This past semester was more than I ever expected; I do not even know where to begin. I participated in the Discover the World program through St. John’s… |
|
Dr. Oz and Raspberry Ketones...
June 1, 2012 - Clinical , In the News / Politics , Professional Advice / Opinions By: Lila Ahmed, Pharm.D. Candidate c/o 2013 – Whether you wish to admit it or not, all of us have watched or at least heard of the Dr. Oz Show. I am sure that many of us encounter patients in the pharmacy who say, “I saw this on Dr. Oz; where could I find it?”… |
|
Effect of Intravenous Ondansetron on QT Interval Prolon...
June 1, 2012 - Clinical By: Raymond Wu, Pharm.D. Candidate c/o 2013 The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used in the prevention and treatment of nausea and vomiting in the inpatient setting.1 Overall, ondansetron is a well-tolerated medication with few side effects.1 Constipation, dizziness, and headache are the most commonly reported side effects associated… |
|
Five Lessons Learned from Being an Assistant Dean...
June 1, 2012 - Featured , Professional Advice / Opinions By: Laura Gianni Augusto, B.S., Pharm.D., Associate Clinical Professor, Department of Clinical Pharmacy Practice – Laura Gianni Augusto, Pharm.D., R.Ph. is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Health Sciences. She served as Assistant Dean for Experiential Pharmacy Education from 2007 to 2011.… |
|
Impact of Gender and Race on the Efficacy on Opiods...
June 1, 2012 - Clinical , Featured By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 – Pain is a very difficult condition to manage, as clinicians have only subjective findings to work with. Opioid medications are currently the cornerstones for the management of moderate to severe pain; however, it is often problematic to determine a patient’s real ‘need’ for opioids. Physicians’ clinical… |
|
Matching Challenge: Look-Alike, Sound-Alikes...
June 1, 2012 - Puzzles By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 – The following medications are easily confused. Try to match each one with its corresponding fun fact. This capsule should be swallowed whole; if chewed or dissolved orally, oropharyngeal anesthesia may occur, which poses a choking hazard. Drinking a glass of water can help bypass this potential adverse… |
|
My Pharmacy Journey...
June 1, 2012 - Professional Advice / Opinions By: Jena Marion, Pharm.D. Candidate c/o 2013 – I have traveled a lot these past few years. I have packed and unpacked suitcases, measured three-ounce bottles of liquids, and printed plenty of boarding passes. Most of my trips were for business, but a few were for pleasure. Pharmacy, however, followed me along on each one… |
|
Naloxone Distribution Programs...
June 1, 2012 - Clinical , Featured , In the News / Politics By: Mahdieh Danesh Yazdi, Associate Student Editor, with Special Thanks to Dr. Tomasz Jodlowski for his contributions to this article – In the 1990s, major urban and rural areas across the United States grappled with a common problem: drug addiction. At that time, the drugs of choice were illicit substances (i.e. heroin). In order to combat… |
|
Proton Pump Inhibitor Use and Complications...
June 1, 2012 - Clinical By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 – We see proton pump inhibitors (PPIs) used in many medication regimens, but it is unknown whether the majority of patients receive these medications for appropriate durations or indications. For all labeled indications, other than Zollinger-Ellison Syndrome (a rare condition characterized by damaging gastrin hypersecretion and subsequent hydrochloric… |
|
Puzzle: Word Search...
June 1, 2012 - Puzzles By: Marie Huang – C F E P I A I I M L R O I I M I T I T M I I Y L G N C E F T A Z I D I M E T L E N I C A K I M A N V O… |
|
Reflection on my 4th Year of Pharmacy...
June 1, 2012 - Professional Advice / Opinions By: SlanixPaul T. Alex, Pharm.D. Candidate c/o 2014 – Progressing into one’s fourth year of college is usually a time of mixed emotions for the average college student. A melting pot of excitement and a sense of accomplishment at the thought of finally graduating after four years of hard work combined with a tinge of… |
|
Rho Chi Executive Board Member Insight: Bethsy M. Jacob...
June 1, 2012 - Professional Advice / Opinions By: Mohammad A. Rattu, Pharm.D. Candidate c/o 2012 – We sometimes need to step back and look at our foundations for success. Clearly, without the support of past and present Rho Chi executive board members, there would be no Rho Chi Post newsletter. From our May to September issues, we will learn about each of… |
|
Risk versus Benefit: Prescription to Over the Counter M...
June 1, 2012 - Professional Advice / Opinions By: Maria A. Sorbera, Pharm.D. Candidate c/o 2013 – Maria Sorbera was the 2011-2012 President of the Rho Chi Beta Theta Chapter at the Arnold & Marie Schwartz College of Pharmacy at Long Island University (LIU). She is a strong advocate of networking with fellow pharmacists regardless of their area of expertise, as well… |
|
Student Pharmacist Star of the Month: Albana Alili...
June 1, 2012 - Professional Advice / Opinions By: Marie Huang – Each month, the Rho Chi Post has the wonderful opportunity to sit down with an inspiring leader among the student pharmacists here at St. John’s University College of Pharmacy and Health Sciences – someone who is not afraid to stand apart from the crowd and can be the change he… |
|
The Challenges of Pediatric Clinical Drug Trials and Dr...
June 1, 2012 - Clinical , Featured , Professional Advice / Opinions By: Shannon Tellier, Associate Student Editor – The disease burden in children outweighs the number of pediatric clinical drug trials currently being conducted. The lack of data in pediatrics leads to drugs being used off-label and without sufficient knowledge of doses, tolerability, and efficacy. In 1975, only 22% of products in the electronic Physicians’ Desk… |
|
The End of an Era...
June 1, 2012 - Professional Advice / Opinions By: Pooja Patel, Pharm.D. Candidate c/o 2013 – The ‘end of an era’ is a fitting way to describe my rotation this past February with Dr. Gladys El-Chaar at Steven and Alexandra Cohen’s Children’s Medical Center of New York. As many have heard, Dr. El-Chaar shifted from her long-standing position at Long Island Jewish Medical… |
|
Transplantation in HIV +/- HBV/HCV Patients...
June 1, 2012 - Clinical , Featured By: Jayoung Park, Pharm.D. Candidate c/o 2013 – Traditionally, human immunodeficiency virus (HIV)-infected patients have generally been excluded from organ transplantation.1 One of the principal concerns was that immunosuppression would accelerate HIV/acquired immune deficiency syndrome (AIDS), resulting in increased mortality and a “waste” of organs.1 A study entitled, “Opportunistic Infections and Neoplasms Following Liver and… |